Citizens Maintains Market Outperform on Precigen, Raises Price Target to $12
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $11 to $12.
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $11 to $12.